100 related articles for article (PubMed ID: 31776192)
1. High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing.
Landry ML; Topal JE; Estis J; Katzenbach P; Nolan N; Sandlund J
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776192
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a Gastrointestinal Pathogen Panel Immunoassay in Stool Testing of Patients with Suspected
Krutova M; Briksi A; Tkadlec J; Zajac M; Matejkova J; Nyc O; Drevinek P
J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31391230
[No Abstract] [Full Text] [Related]
3. Clinical outcomes and treatment necessity in patients with toxin-negative Clostridioides difficile stool samples.
Cho DH; Kim SH; Jeon CH; Kim HT; Park KJ; Kim J; Kwak J; Kwan BS; Kong S; Lee JW; Kim KM; Wi YM
Ann Clin Microbiol Antimicrob; 2024 Apr; 23(1):35. PubMed ID: 38664689
[TBL] [Abstract][Full Text] [Related]
4. Laboratory diagnosis of Clostridioides difficile infection in symptomatic patients: what can we do better?
Maestri AC; Nogueira KS; Mialski R; Dos Santos EM; Kraft L; Raboni SM
Braz J Microbiol; 2023 Jun; 54(2):849-857. PubMed ID: 36991280
[TBL] [Abstract][Full Text] [Related]
5. Two-step Testing for Clostridioides Difficile is Inadequate in Differentiating Infection From Colonization in Children.
Parnell JM; Fazili I; Bloch SC; Lacy DB; Garcia-Lopez VA; Bernard R; Skaar EP; Edwards KM; Nicholson MR
J Pediatr Gastroenterol Nutr; 2021 Mar; 72(3):378-383. PubMed ID: 32925555
[TBL] [Abstract][Full Text] [Related]
6. Comparison of rectal swabs and fecal samples for the detection of
Huletsky A; Loo VG; Longtin Y; Longtin J; Trottier S; Tremblay CL; Gilca R; Lavallée C; Brochu É; Bérubé È; Bastien M; Bernier M; Gagnon M; Frenette J; Bestman-Smith J; Deschênes L; Bergeron MG
Microbiol Spectr; 2024 Jun; 12(6):e0022524. PubMed ID: 38687067
[TBL] [Abstract][Full Text] [Related]
7. Impact of the Reverse 2-Step Algorithm for
Hilt EE; Vaughn BP; Galdys AL; Evans MD; Ferrieri P
Open Forum Infect Dis; 2024 May; 11(5):ofae244. PubMed ID: 38756762
[TBL] [Abstract][Full Text] [Related]
8. Detection of Clostridium difficile among diarrheic children using cultural and polymerase chain reaction technique.
Ali BN; Saeed AY; Abdulmawjood A
J Infect Dev Ctries; 2023 Oct; 17(10):1452-1457. PubMed ID: 37956379
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and outcomes of
Crone AS; Wright LM; Cheknis A; Johnson S; Pacheco SM; Skinner AM
Infect Control Hosp Epidemiol; 2024 Jan; 45(1):57-62. PubMed ID: 37462099
[TBL] [Abstract][Full Text] [Related]
10. High Prevalence of Toxigenic and Nontoxigenic Clostridium difficile Strains in Malaysia.
Riley TV; Collins DA; Karunakaran R; Kahar MA; Adnan A; Hassan SA; Zainul NH; Rustam FRM; Wahab ZA; Ramli R; Lee YY; Hassan H
J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29563206
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of toxigenic
Kameli N; Basode VK; Abdulhaq A; Alamoudi MUA; Zain KAM; Ghzwani AH
Libyan J Med; 2024 Dec; 19(1):2294571. PubMed ID: 38112195
[No Abstract] [Full Text] [Related]
12. Harnessing the glucosyltransferase activities of Clostridium difficile for functional studies of toxins A and B.
Darkoh C; Kaplan HB; Dupont HL
J Clin Microbiol; 2011 Aug; 49(8):2933-41. PubMed ID: 21653766
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a two step testing algorithm to improve diagnostic accuracy and stewardship of Clostridioides difficile infections.
Bettger CC; Giancola SE; Cybulski RJ; Okulicz JF; Barsoumian AE
BMC Res Notes; 2023 Aug; 16(1):172. PubMed ID: 37580824
[TBL] [Abstract][Full Text] [Related]
14. Toxin A-Predominant Pathogenic Clostridioides difficile: A Novel Clinical Phenotype.
Lin Q; Pollock NR; Banz A; Lantz A; Xu H; Gu L; Gerding DN; Garey KW; Gonzales-Luna AJ; Zhao M; Song L; Duffy DC; Kelly CP; Chen X
Clin Infect Dis; 2020 Jun; 70(12):2628-2633. PubMed ID: 31400280
[TBL] [Abstract][Full Text] [Related]
15. Dual Reporting of Clostridioides difficile PCR and Predicted Toxin Result Based on PCR Cycle Threshold Reduces Treatment of Toxin-Negative Patients without Increases in Adverse Outcomes.
Hitchcock MM; Holubar M; Hogan CA; Tompkins LS; Banaei N
J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31511334
[TBL] [Abstract][Full Text] [Related]
16. Identification of Clostridium innocuum hypothetical protein that is cross-reactive with C. difficile anti-toxin antibodies.
Cherny KE; Balaji A; Mukherjee J; Goo YA; Hauser AR; Ozer E; Satchell KJF; Bachta KER; Kochan TJ; Mitra SD; Kociolek LK
Anaerobe; 2022 Jun; 75():102555. PubMed ID: 35367613
[TBL] [Abstract][Full Text] [Related]
17. Fecal calprotectin concentrations in cancer patients with Clostridium difficile infection.
He T; Kaplan SE; Gomez LA; Lu X; Ramanathan LV; Kamboj M; Tang YW
Eur J Clin Microbiol Infect Dis; 2018 Dec; 37(12):2341-2346. PubMed ID: 30242543
[TBL] [Abstract][Full Text] [Related]
18. Contribution to Clostridium Difficile Transmission of Symptomatic Patients With Toxigenic Strains Who Are Fecal Toxin Negative.
Mawer DPC; Eyre DW; Griffiths D; Fawley WN; Martin JSH; Quan TP; Peto TEA; Crook DW; Walker AS; Wilcox MH
Clin Infect Dis; 2017 May; 64(9):1163-1170. PubMed ID: 28158441
[TBL] [Abstract][Full Text] [Related]
19. Baseline stool toxin concentration is associated with risk of recurrence in children with
Sandora TJ; Kociolek LK; Williams DN; Daugherty K; Geer C; Cuddemi C; Chen X; Xu H; Savage TJ; Banz A; Garey KW; Gonzales-Luna AJ; Kelly CP; Pollock NR
Infect Control Hosp Epidemiol; 2023 Sep; 44(9):1403-1409. PubMed ID: 36624698
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Guidance for C. difficile Infections.
van Prehn J; Crobach MJT; Baktash A; Duszenko N; Kuijper EJ
Adv Exp Med Biol; 2024; 1435():33-56. PubMed ID: 38175470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
